Hikal Limited (NSE:HIKAL) is a stock with outstanding fundamental characteristics. When we build an investment case, we need to look at the stock with a holistic perspective. In the case of HIKAL, it ...

Get all latest & breaking news on Hikal Limited. Watch videos, top stories and articles on Hikal Limited at moneycontrol.com.

India, July 13 -- Hikal Ltd offers solutions across the life sciences value chain providing worldclass active ingredients, intermediates and research and development services to global pharmaceuticals ...

How Do You Calculate Hikal's P/E Ratio? The formula for price to earnings is: Price to Earnings Ratio = Price per Share ÷ Earnings per Share (EPS) Or for Hikal: P/E of 15.57 = ₹142.05 ÷ ₹9.12 (Based ...

A simmering ownership dispute between Hikal Ltd’s co-promoter families, the Kalyanis and the Hiremaths, has now become a test of boardroom governance, with proxy advisory firms divided over the ...

India’s Hikal Limited has been hit with an FDA warning letter chiding the drug ingredients manufacturer for failing to uncover the cause of dozens of complaints of metal contamination in its products.

Life sciences company Hikal has opened a High Potency Active Pharmaceutical Ingredient (HPAPI) laboratory at its Research and Technology Innovation Centre in Pune. This new facility enhances Hikal’s ...

MUMBAI, India Hikal and Pfizer have signed a long-term deal under which Hikal will manufacture and supply Pfizer with active pharmaceutical ingredients, according to published reports. Terms of the ...

Mumbai: Pharmaceuticals and chemicals company Hikal’s non-executive director Sugandha Hiremath has accused her brother, Bharat Forge CMD Baba Kalyani, of trying to “marginalise and oust” her and her ...

"The company's API and intermediates manufacturing facility located at Jigani, Bangalore, was recently inspected by the United States Food and Drug Administration (USFDA) in compliance with their ...